These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37909242)

  • 1. Inhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment.
    Askew KE; Beverley J; Sigfridsson E; Szymkowiak S; Emelianova K; Dando O; Hardingham GE; Duncombe J; Hennessy E; Koudelka J; Samarasekera N; Salman RA; Smith C; Tavares AAS; Gomez-Nicola D; Kalaria RN; McColl BW; Horsburgh K
    Glia; 2024 Feb; 72(2):375-395. PubMed ID: 37909242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline protects against microgliopathy in a Csf1r haplo-insufficient mouse model of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).
    Li X; Hu B; Guan X; Wang Z; Zhou Y; Sun H; Zhang X; Li Y; Huang X; Zhao Y; Wang X; Xu H; Zhang YW; Wang Z; Zheng H
    J Neuroinflammation; 2023 May; 20(1):134. PubMed ID: 37259140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering glial contributions to CSF1R-related disorder via single-nuclear transcriptomic profiling: a case study.
    Pan J; Fores-Martos J; Delpirou Nouh C; Jensen TD; Vallejo K; Cayrol R; Ahmadian S; Ashley EA; Greicius MD; Cobos I
    Acta Neuropathol Commun; 2024 Aug; 12(1):139. PubMed ID: 39217398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of microglia ameliorates white matter injury and cognitive impairment in a mouse chronic cerebral hypoperfusion model.
    Kakae M; Tobori S; Morishima M; Nagayasu K; Shirakawa H; Kaneko S
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1040-1044. PubMed ID: 31097227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy.
    Kempthorne L; Yoon H; Madore C; Smith S; Wszolek ZK; Rademakers R; Kim J; Butovsky O; Dickson DW
    Acta Neuropathol Commun; 2020 May; 8(1):72. PubMed ID: 32430064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of Nrf2 exacerbates white matter damage and microglia/macrophage levels in a mouse model of vascular cognitive impairment.
    Sigfridsson E; Marangoni M; Hardingham GE; Horsburgh K; Fowler JH
    J Neuroinflammation; 2020 Dec; 17(1):367. PubMed ID: 33261626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).
    Chitu V; Gokhan S; Gulinello M; Branch CA; Patil M; Basu R; Stoddart C; Mehler MF; Stanley ER
    Neurobiol Dis; 2015 Feb; 74():219-28. PubMed ID: 25497733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
    Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
    J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
    Front Immunol; 2020; 11():579000. PubMed ID: 33162994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo.
    Oosterhof N; Kuil LE; van der Linde HC; Burm SM; Berdowski W; van Ijcken WFJ; van Swieten JC; Hol EM; Verheijen MHG; van Ham TJ
    Cell Rep; 2018 Jul; 24(5):1203-1217.e6. PubMed ID: 30067976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.
    Martínez-Muriana A; Mancuso R; Francos-Quijorna I; Olmos-Alonso A; Osta R; Perry VH; Navarro X; Gomez-Nicola D; López-Vales R
    Sci Rep; 2016 May; 6():25663. PubMed ID: 27174644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice.
    Wang Y; Wernersbach I; Strehle J; Li S; Appel D; Klein M; Ritter K; Hummel R; Tegeder I; Schäfer MKE
    Brain Behav Immun; 2022 Nov; 106():49-66. PubMed ID: 35933030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial loss of function of colony-stimulating factor 1 receptor in a patient with white matter abnormalities.
    Konno T; Miura T; Harriott AM; Mezaki N; Edwards ES; Rademakers R; Ross OA; Meschia JF; Ikeuchi T; Wszolek ZK
    Eur J Neurol; 2018 Jun; 25(6):875-881. PubMed ID: 29509319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen promotes white matter recovery and cognitive functions in male mice after chronic hypoperfusion.
    Chen Y; Tian Y; Tian H; Huang Q; Fang Y; Wang W; Wan Y; Pan D; Xie M
    Neurochem Int; 2019 Dec; 131():104566. PubMed ID: 31593788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates.
    Poulen G; Aloy E; Bringuier CM; Mestre-Francés N; Artus EVF; Cardoso M; Perez JC; Goze-Bac C; Boukhaddaoui H; Lonjon N; Gerber YN; Perrin FE
    Theranostics; 2021; 11(18):8640-8659. PubMed ID: 34522204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia protect against age-associated brain pathologies.
    Munro DAD; Bestard-Cuche N; McQuaid C; Chagnot A; Shabestari SK; Chadarevian JP; Maheshwari U; Szymkowiak S; Morris K; Mohammad M; Corsinotti A; Bradford B; Mabbott N; Lennen RJ; Jansen MA; Pridans C; McColl BW; Keller A; Blurton-Jones M; Montagne A; Williams A; Priller J
    Neuron; 2024 Aug; 112(16):2732-2748.e8. PubMed ID: 38897208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.